Among 30,000 attendees at American Society of Hematology (ASH) Annual Meeting, we’re proud to have Roswell Park represented—bringing our physicians together with peers and industry partners to collaborate, connect, and help advance new therapies for our patients. #HematologyOncology #ASH2025 | Roswell Park Comprehensive Cancer Center

27 reactions | At the American Society of Hematology's (ASH) 58th Annual Meeting, we presented an analysis on treatment adherence rates in atrial fibrillation (AF). Did you know that 73% of AF patients with good stroke knowledge prefer to be involved in their treatment decisions? Watch this informative video below to learn more about why adherence and an open physician-patient dialogue are so important when discussing AF and management options. | Boehringer Ingelheim | Facebook